CA2580887A1 - Systeme boitier pour capteur de glucose - Google Patents

Systeme boitier pour capteur de glucose Download PDF

Info

Publication number: CA2580887A1
Authority: CA; Canada
Prior art keywords: glucose; temperature; glucose sensor; sensor; exposure
Prior art date: 1999-02-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002580887A

Other languages

English (en)

Inventor

K. Collin Mcivor

James L. Cabernoch

Kevin D. Branch

Nannette M. Van Antwerp

Edgardo C. Halili

John J. Mastrototaro

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Medtronic Minimed Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-25

Filing date

2000-02-15

Publication date

2000-08-31

2000-02-10 Priority claimed from US09/501,848 external-priority patent/US6360888B1/en

2000-02-15 Application filed by Individual filed Critical Individual

2000-02-15 Priority claimed from CA002568226A external-priority patent/CA2568226C/fr

2000-08-31 Publication of CA2580887A1 publication Critical patent/CA2580887A1/fr

Status Abandoned legal-status Critical Current

Links

WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 218
239000008103 glucose Substances 0.000 title claims abstract description 218
239000000758 substrate Substances 0.000 claims description 9
102000004190 Enzymes Human genes 0.000 claims description 8
108090000790 Enzymes Proteins 0.000 claims description 8
230000001681 protective effect Effects 0.000 abstract description 45
238000000034 method Methods 0.000 abstract description 25
230000001954 sterilising effect Effects 0.000 abstract description 24
238000004513 sizing Methods 0.000 abstract description 3
238000007920 subcutaneous administration Methods 0.000 description 25
239000000463 material Substances 0.000 description 24
238000004659 sterilization and disinfection Methods 0.000 description 20
238000003780 insertion Methods 0.000 description 19
230000037431 insertion Effects 0.000 description 19
239000010410 layer Substances 0.000 description 13
239000008280 blood Substances 0.000 description 11
210000004369 blood Anatomy 0.000 description 11
238000004891 communication Methods 0.000 description 10
230000008859 change Effects 0.000 description 9
229940079593 drug Drugs 0.000 description 9
239000003814 drug Substances 0.000 description 9
238000004806 packaging method and process Methods 0.000 description 9
238000010894 electron beam technology Methods 0.000 description 8
230000008569 process Effects 0.000 description 7
238000001802 infusion Methods 0.000 description 6
238000012544 monitoring process Methods 0.000 description 6
238000003860 storage Methods 0.000 description 6
239000010409 thin film Substances 0.000 description 6
210000001124 body fluid Anatomy 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
230000006641 stabilisation Effects 0.000 description 5
238000011105 stabilization Methods 0.000 description 5
239000012790 adhesive layer Substances 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
230000005855 radiation Effects 0.000 description 4
239000000126 substance Substances 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
238000004458 analytical method Methods 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
239000004020 conductor Substances 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
238000012360 testing method Methods 0.000 description 3
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
238000011109 contamination Methods 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000005518 electrochemistry Effects 0.000 description 2
-1 electrodes Substances 0.000 description 2
210000003722 extracellular fluid Anatomy 0.000 description 2
239000012530 fluid Substances 0.000 description 2
230000006870 function Effects 0.000 description 2
239000011521 glass Substances 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
230000003993 interaction Effects 0.000 description 2
230000007774 longterm Effects 0.000 description 2
239000000203 mixture Substances 0.000 description 2
239000004033 plastic Substances 0.000 description 2
NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
230000000087 stabilizing effect Effects 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
241000219198 Brassica Species 0.000 description 1
235000003351 Brassica cretica Nutrition 0.000 description 1
235000003343 Brassica rupestris Nutrition 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
210000001367 artery Anatomy 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
229940107161 cholesterol Drugs 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
239000002131 composite material Substances 0.000 description 1
238000012937 correction Methods 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
239000002274 desiccant Substances 0.000 description 1
238000013461 design Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
239000000806 elastomer Substances 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
230000036541 health Effects 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
238000007654 immersion Methods 0.000 description 1
230000036512 infertility Effects 0.000 description 1
238000009413 insulation Methods 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
230000007257 malfunction Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000010339 medical test Methods 0.000 description 1
238000013160 medical therapy Methods 0.000 description 1
238000002483 medication Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000005055 memory storage Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
235000010460 mustard Nutrition 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000005022 packaging material Substances 0.000 description 1
206010033675 panniculitis Diseases 0.000 description 1
229920001721 polyimide Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
230000004044 response Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
229920002631 room-temperature vulcanizate silicone Polymers 0.000 description 1
238000007789 sealing Methods 0.000 description 1
238000010187 selection method Methods 0.000 description 1
239000004590 silicone sealant Substances 0.000 description 1
229910001923 silver oxide Inorganic materials 0.000 description 1
230000005476 size effect Effects 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000012414 sterilization procedure Methods 0.000 description 1
210000004304 subcutaneous tissue Anatomy 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
239000002699 waste material Substances 0.000 description 1
238000003466 welding Methods 0.000 description 1

Landscapes

Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

CA002580887A 1999-02-25 2000-02-15 Systeme boitier pour capteur de glucose Abandoned CA2580887A1 (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US12165599P	1999-02-25	1999-02-25
US60/121655		1999-02-25
US09/501848		2000-02-10
US09/501,848 US6360888B1 (en)	1999-02-25	2000-02-10	Glucose sensor package system
CA002568226A CA2568226C (fr)	1999-02-25	2000-02-15	Systeme boitier pour capteur de glucose

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002568226A Division CA2568226C (fr)	1999-02-25	2000-02-15	Systeme boitier pour capteur de glucose

Publications (1)

Publication Number	Publication Date
CA2580887A1 true CA2580887A1 (fr)	2000-08-31

Family

ID=38162439

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002580887A Abandoned CA2580887A1 (fr)	1999-02-25	2000-02-15	Systeme boitier pour capteur de glucose

Country Status (1)

Country	Link
CA (1)	CA2580887A1 (fr)

2000
- 2000-02-15 CA CA002580887A patent/CA2580887A1/fr not_active Abandoned

Publication	Publication Date	Title
US6520326B2 (en)	2003-02-18	Glucose sensor package system
US6248067B1 (en)	2001-06-19	Analyte sensor and holter-type monitor system and method of using the same
US20230371860A1 (en)	2023-11-23	Detecting an analyte in a body fluid
US7098803B2 (en)	2006-08-29	Telemetered characteristic monitor system and method of using the same
EP3909506B1 (fr)	2023-06-07	Dispositif médical pour détecter au moins un analyte dans un fluide corporel
US6424847B1 (en)	2002-07-23	Glucose monitor calibration methods
US20090085768A1 (en)	2009-04-02	Glucose sensor transceiver
US20100168539A1 (en)	2010-07-01	Method and/or system for estimating glycation of hemoglobin
CA2388689A1 (fr)	2000-12-28	Systeme moniteur de caracteristiques utilise avec un capteur d'analyte
CA2568226C (fr)	2007-06-12	Systeme boitier pour capteur de glucose
CA2580887A1 (fr)	2000-08-31	Systeme boitier pour capteur de glucose

Legal Events

Date	Code	Title	Description
2007-03-23	EEER	Examination request
2011-11-07	FZDE	Dead